Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021
HILLSIDE, NJ / ACCESSWIRE / September 2, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial...
News
Establishment Labs Launches Motiva Flora Tissue Expander in Europe and Other CE Mark Countries
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and...
CordovaCann (CSE:CDVA / OTCQB:LVRLF) Provides Update On Star Buds Cannabis Co. Retail Operations
Star Buds Cannabis Co. Retail Revenues Reach Another Record High in AugustTORONTO, ON / ACCESSWIRE / September 2, 2021 /...
Secarna Pharmaceuticals GmbH & Co. KG: Secarna Pharmaceuticals and Evotec Expand Strategic Partnership in the Field of Antisense Drug Discovery
In addition to the successful ongoing collaboration on a co-owned LNAplus TM ASO pipeline, Secarna and Evotec now also start...
SURE Retractors Inc. Raises Over $1.5M of Series Seed Preferred Stock
GLASGOW, UK / ACCESSWIRE / September 2, 2021 / SURE Retractors Inc. ("SURE"), a medical devices company founded in Glasgow,...
SheepMedical to Present at the 10th Annual Gateway Conference on September 8, 2021
TOKYO, JAPAN / ACCESSWIRE / September 2, 2021 / SheepMedical Co., Ltd. ("SheepMedical"), a medical technology company driving the digital...
BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program
Issued Patent Grants Protection for an Implantable Scaffold using Brown Adipose Derived Stem Cells and Methods of Use MELVILLE, N.Y.,...
ResMed Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer,...
Supernus to Participate in Upcoming September Investor Conferences
ROCKVILLE, Md., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
Evolus Announces Participation in September Investment Conferences
NEWPORT BEACH, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric...
Dave Richardson Appointed Special Advisor To Boosh Foods
Vancouver, British Columbia--(Newsfile Corp. - September 2, 2021) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) ("Boosh" or the "Company") is pleased...
Awakn Life Sciences Announces DTC Eligibility
Toronto, Ontario--(Newsfile Corp. - September 2, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a...
Mycrodose Therapeutics Announces Expansion of Southern California Pharmaceutical Laboratory
San Diego, California--(Newsfile Corp. - September 2, 2021) - Mycrodose Therapeutics, a US pharmaceutical company focused on developing advanced drug...
Model N to Present at the Jefferies Virtual Software Conference
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leader in cloud revenue management solutions, today announced that John Ederer,...
Vantage Announces the Launch of Healthcare and E&S Excess Casualty Insurance Businesses in Bermuda and the US
HAMILTON, Bermuda--(BUSINESS WIRE)--Vantage Group Holdings Ltd. (Vantage) is pleased to announce it continues the build-out of its insurance platform, introducing...
LENSAR to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser...
Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally
Transaction valued at $156.00 per Hillrom Share for an All-Cash Purchase Price of $10.5 Billion Brings together two leading medical...
Evotec Announces Bristol Myers Squibb Opt-in of EVT8683 as the First Programme from iPSC-based Neurodegeneration Collaboration
BRISTOL MYERS SQUIBB EXERCISES ITS OPTION TO ENTER INTO A GLOBAL LICENSE AGREEMENT FOR THE FIRST PROGRAMME FROM THE COMPANIES'...
Relief Reports Regulatory Clearance in Germany to Commence a Multicenter, Double-blind, Randomized Phase 2 Clinical Trial to Evaluate Inhaled Aviptadil for the Treatment of Sarcoidosis
GENEVA, SWITZERLAND / ACCESSWIRE / September 2, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF) ("Relief"), a biopharmaceutical company seeking to...
Relay and Fio Deployed for COVID-19 Testing to Toronto’s FIFA World Cup(TM) Qualifying Matches, in advance of the FIFA World Cup Qatar 2022(TM)
Toronto, Ontario--(Newsfile Corp. - September 2, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") and...